Durham, NC, United States of America

Xiaofei Liang

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Xiaofei Liang

Introduction

Xiaofei Liang is a notable inventor based in Durham, NC, who has made significant contributions to the field of pharmaceuticals. He holds three patents that focus on innovative compounds and methods for treating infections caused by Gram-negative bacteria. His work is essential in advancing medical treatments and improving patient outcomes.

Latest Patents

Liang's latest patents include the development of benzoylglycine derivatives and methods of making and using these compounds. These compounds are defined by specific formulae and pharmaceutically acceptable salts, which are crucial for their effectiveness. The disclosed compounds are particularly useful for treating infections caused by Gram-negative bacteria, showcasing Liang's commitment to addressing critical health challenges.

Career Highlights

Throughout his career, Xiaofei Liang has worked at prestigious institutions such as Duke University and the University of North Carolina at Chapel Hill. His experience in these research environments has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Liang has collaborated with notable colleagues, including Pei Zhou and Eric John Toone. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Xiaofei Liang's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, particularly in combating bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…